PPPooja Patel

Pooja Patel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pooja Patel has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dermatological Effects of a Beeswax-Pine Resin Mixture on Abdominal Skin: A Proof-of-Concept Study Supporting the Development of an Affordable Investigational Ostomy Pouching System in Low-Income Regions

    by Darienne Rogers, Joanna Peng, Amy Guan, Westbrook Jensen, Jessica Alvarez, Pooja Patel, Ayesiga Herman, Dorothy Dow, Ann Saterbak, Amy Barto

    PURPOSE: The purpose of this study was to compare short-term abdominal skin responses, including erythema and edema, after the application of 2 beeswax-pine resin mixtures and a hydrocolloid sample prepared from an ostomy barrier ring used as an active comparator. DESIGN: Proof-of-concept, blinded, within-participant comparative skin irritation study. SUBJECTS AND SETTING: The sample comprised 50 healthy volunteers over 18 years of age; 54% (n = 27) were female; 68% (n = 34) were White, 18% (n = 9) were Asian, 4% (n = 2) were Black, 6% (n = 3) were multiracial, and 12% (n = 6) were Hispanic. The study setting was Duke University campus, located in the southeastern region of the United States. METHODS: Participants simultaneously wore 3 samples: the first was a beeswax-pine resin sample with beeswax sourced in the United States; the second was a beeswax-pine resin sample with beeswax sourced from Tanzania; and the third was a hydrocolloid active comparator from an ostomy barrier ring. Participants were examined by a physician on day 1 for preexisting dermatologic conditions on the lower abdomen, after which the 3 samples were placed and each covered with a thin-film wound dressing. The samples and dressings were removed and replaced daily, and a daily survey prompted self-reporting of adverse effects (itching and redness). Participants returned on day 7 for follow-up evaluation. The physician rated edema and erythema using the Draize skin scale (a previously validated instrument). Equivalence of the difference in mean day 7 combined Draize scores between each beeswax-pine resin mixture and the active comparator was tested using the Schuirmann two one-sided test procedure for equivalence. RESULTS: Day 7 Draize score assessments were analyzed from 35 subjects; 15 did not complete data collection for all end points. Both the United States and Tanzanian sourced beeswax-pine resin preparations were equivalent to the active comparator based on the mean differences in Draize scores (erythema plus edema) using the two one-sided test procedures for equivalence. CONCLUSIONS: The beeswax-pine resin mixtures did not produce increased short-term skin irritation when compared with the hydrocolloid active comparator, supporting further evaluation of this material as a skin-contact adhesive in an investigational ostomy pouching system.

  • Open Access

    Extraintestinal Manifestations and Family History of Inflammatory Bowel Disease Increase the Risk of Pouchitis in a State-Level Epidemiology Study

    by Edward L. Barnes, Michael S. Dunn, Jean Ashburn, Amy Barto, Richard Bloomfeld, Ashley Cairns, Kurren Mehta, Pooja Patel, Jennifer Dziwis, Scott Esckilsen, et al.

    INTRODUCTION: Our understanding of the epidemiology of inflammatory conditions of the pouch and effectiveness of treatment is largely based on selected populations. We created a state-level registry to evaluate the incidence of pouchitis and the effectiveness of treatments used in an initial episode of pouchitis. METHODS: In a state-level retrospective cohort of all patients undergoing proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis between January 1, 2018, and December 31, 2020, we evaluated the incidence of pouchitis and compared the proportion of patients developing recurrent pouchitis and chronic antibiotic-dependent pouchitis according to initial antibiotic therapy. RESULTS: A total of 177 patients underwent surgery with 49 (28%) developing pouchitis within the 12 months after the final stage of IPAA. Patients with extraintestinal manifestations of inflammatory bowel disease (IBD) were significantly more likely to develop pouchitis within the first 12 months after IPAA (adjusted odds ratio 2.45, 95% confidence interval 1.03–5.81) after adjusting for family history of IBD (adjusted odds ratio 3.50, 95% 1.50–8.18). When comparing the proportion of patients who developed recurrent pouchitis or chronic antibiotic-dependent pouchitis with those who experienced an isolated episode of pouchitis, there were no significant differences among the initial antibiotic regimens used. DISCUSSION: In a state-level examination of outcomes after IPAA for ulcerative colitis, patients with extraintestinal manifestations of IBD were more likely to develop pouchitis; however, the initial antibiotic regimen chosen did not seem to affect long-term outcomes.